Kwang Lee Net Worth & Insider Trades

Kwang Lee - Principal Accounting Officer, Galena Biopharma, Inc

As of December 7, 2011

What is Kwang Lee's Net Worth?

The current estimated net worth of Galena Biopharma, Inc's Principal Accounting Officer, Kwang Lee, is estimated to be about $3K . Kwang Lee owns about 5,000 units of Galena Biopharma, Inc common stock. Recently at Galena Biopharma, Inc, Kwang Lee has sold an estimated value of $0 worth.

What is Kwang Lee's Past Insider Trading?

Kwang Lee's largest purchase order was 5,000 units , worth over $3K on December 7, 2011. In total, Kwang Lee has made about 1 transaction recently at Galena Biopharma, Inc. Kwang Lee usually trades in December, with the busiest year in 2011.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Kwang Lee's' Mailing Address?

  • Mailing address is 310 N State Street, Suite 208 Lake Oswego OR 97034 OR

What are Galena Biopharma, Inc's Past Insider Trades?

Galena Biopharma, Inc's most recent insider trade came on June 22, 2017 by Rudolph Nisi who sold 500 units worth $273.05 . In the last 6 years, insiders at Galena Biopharma, Inc have sold an estimated value of $18.62M and bought an estimated value of $4.22M worth of shares. Insider trading is most common in January, with the busiest year in 2017. The most active traders at the company are Sanford Hillsberg, Director,  Mark W Schwartz, President & CEO,  and Rudolph Nisi, Director .

Galena Biopharma, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...